The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York BPC 157: What It Is, What We Know, and Why Its Use for Arthritis Remains Unproven San Diego Orthobiologics Medical Group Injectable Peptides: Out of the Back Alley and Into the Light? Berkley Lifesciences BPC 157 Benefits: Heal & Thrive in 2025